Company / Operating Cash Flow per Share
Cardiff Oncology, Inc. Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$0.57
FY2025
5-year range
-$0.76 / -$0.44
FY2021-FY2025
Trend
+17.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 10 years, ranging from $-31.75 in FY2018 to $-0.43 in FY2016.
Based on SEC 10-K filings.
-0.57 in FY2025.
Improved from $-0.76 to $-0.57 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 17.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
- Lowest operating cash flow per share in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -6.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.57 | +17.5% |
| FY2024 | -$0.69 | +8.7% |
| FY2023 | -$0.76 | -37.9% |
| FY2022 | -$0.55 | -23.8% |
| FY2021 | -$0.44 | +76.6% |
| FY2020 | -$1.90 | +45.2% |
| FY2019 | -$3.46 | +89.1% |
| FY2018 | -$31.75 | -3040.1% |
| FY2017 | -$1.01 | -136.3% |
| FY2016 | -$0.43 | +63.4% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026